Tscan Therapeutics Inc (TCRX) support and resistance · rev $2.0M
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
This page maps Tscan Therapeutics Inc (TCRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
TCRX currently screens at market cap $62.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TCRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TCRX quote page for the session range and the stock page for the full model.
Not investment advice.